88
Growth Score in past quarter
pts
Heat Score 88 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
233578
Anergix is a Biotechnology Platform.
- Lynn Foster: CEO
- Katherine Louie: Owner,Founder & CTO
About the Company
Anergix LLC has developed a proprietary cell therapy technology for the deliver of peptides in vivo. Their lead program focuses on the treatment of multiple sclerosis (MS) in which patients will be receive peptides, whose sequences are derived from the proteins of myelin, delivered in vivo. Anergix was awarded an NIH SBIR grant for studies to
satisfy FDA requirements prior to the initiation of a Phase I clinical trial.
Women Founded
Women Led